Jonathan Sprent

Prof. Dr. Jonathan Sprent

orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2009 in Journal of Experimental Medicine
Verified
Journal Article
Open access
KWKylie E. Webster
Kylie E. Webster
SWStacey Walters
Stacey Walters
RKRachel E. Kohler
Rachel E. Kohler
TMTomas Mrkvan
Tomas Mrkvan
OBOnur Boyman
Onur Boyman
JSJonathan Sprent
Jonathan Sprent
Via a transcription factor, Foxp3, immunoregulatory CD4+CD25+ T cells (T reg cells) play an important role in suppressing the function of other T cells. Adoptively transferring high numbers of T reg cells can reduce the intensity of the immune response, thereby providing an attractive prospect for inducing tolerance. Extending our previous findings, we describe an in vivo approach for inducing rapid expansion of T reg cells by injecting mice with interleukin (IL)-2 mixed with a particular IL-2 monoclonal antibody (mAb). Injection of these IL-2–IL-2 mAb complexes for a short period of 3 d induces a marked (>10-fold) increase in T reg cell numbers in many organs, including the liver and gut as well as the spleen and lymph nodes, and a modest increase in the thymus. The expanded T reg cells survive for 1–2 wk and are highly activated and display superior suppressive function. Pretreating with the IL-2–IL-2 mAb complexes renders the mice resistant to induction of experimental autoimmune encephalomyelitis; combined with rapamycin, the complexes can also be used to treat ongoing disease. In addition, pretreating mice with the complexes induces tolerance to fully major histocompatibility complex–incompatible pancreatic islets in the absence of immunosuppression. Tolerance is robust and the majority of grafts are accepted indefinitely. The approach described for T reg cell expansion has clinical potential for treating autoimmune disease and promoting organ transplantation.

18 May 2011 in Nature Immunology
Verified
Journal Article
Open access
PDF file
JSJonathan Sprent
Jonathan Sprent
CSCharles D Surh
Charles D Surh
Weak T cell antigen receptor (TCR) signals from contact with self ligands act in synergy with antiapoptotic signals induced by interleukin 7 (IL-7) to promote the survival of naive T cells in a resting state. The amount of background TCR signaling in naive T cells is set by post-thymic TCR tuning and operates at an intensity just below that required to induce entry into the cell cycle. Costimulation from higher concentrations of IL-7 and other common γ-chain cytokines can induce T cells to undergo homeostatic proliferation and conversion into cells with a memory phenotype; many of these memory phenotype cells may be the progeny of cells responding to self antigens. The molecular mechanisms that control the conversion of naive resting T cells into memory-phenotype cells TCR-dependent in normal animals are beginning to be understood.

13 June 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MRMark P. Rubinstein
Mark P. Rubinstein
MKMarek Kovar
Marek Kovar
JPJared F. Purton
Jared F. Purton
JCJae-Ho Cho
Jae-Ho Cho
OBOnur Boyman
Onur Boyman
JSJonathan Sprent
Jonathan Sprent
IL-15 is normally presentedin vivoas a cell-associated cytokine bound to IL-15Rα. We show here that the biological activity of soluble IL-15 is much improved after interaction with recombinant soluble IL-15Rα; after injection, soluble IL-15/IL-15Rα complexes rapidly induce strong and selective expansion of memory-phenotype CD8+cells and natural killer cells. These findings imply that binding of IL-15Rα to IL-15 may create a conformational change that potentiates IL-15 recognition by the βγcreceptor on T cells. The enhancing effect of IL-15Rα binding may explain why IL-15 normally functions as a cell-associated cytokine. Significantly, the results with IL-2, a soluble cytokine, are quite different; thus, IL-2 function is markedly inhibited by binding to soluble IL-2Rα.

1 February 2010 in Immunity
Verified
Journal Article
Closed access
JCJae-Ho Cho
Jae-Ho Cho
HKHee-Ok Kim
Hee-Ok Kim
CSCharles D. Surh
Charles D. Surh
JSJonathan Sprent
Jonathan Sprent

30 July 2007 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JCJae-Ho Cho
Jae-Ho Cho
OBOnur Boyman
Onur Boyman
HKHee-Ok Kim
Hee-Ok Kim
BHBumsuk Hahm
Bumsuk Hahm
MRMark P. Rubinstein
Mark P. Rubinstein
JSJonathan Sprent
Jonathan Sprent
In conditions of T lymphopenia, interleukin (IL) 7 levels rise and, via T cell receptor for antigen–self–major histocompatibility complex (MHC) interaction, induce residual naive T cells to proliferate. This pattern of lymphopenia-induced “homeostatic” proliferation is typically quite slow and causes a gradual increase in total T cell numbers and differentiation into cells with features of memory cells. In contrast, we describe a novel form of homeostatic proliferation that occurs when naive T cells encounter raised levels of IL-2 and IL-15 in vivo. In this situation, CD8+ T cells undergo massive expansion and rapid differentiation into effector cells, thus closely resembling the T cell response to foreign antigens. However, the responses induced by IL-2/IL-15 are not seen in MHC-deficient hosts, implying that the responses are driven by self-ligands. Hence, homeostatic proliferation of naive T cells can be either slow or fast, with the quality of the response to self being dictated by the particular cytokine (IL-7 vs. IL-2/IL-15) concerned. The relevance of the data to the gradual transition of naive T cells into memory-phenotype (MP) cells with age is discussed.

15 June 2021 in Science Immunology
Verified
Journal Article
Closed access
PDF file
JSJonathan Sprent
Jonathan Sprent
Cecile KingCecile King
Cecile King
The side effects of SARS-CoV-2 vaccines are often troubling but may merely reflect transient production of type I interferons, a normal physiological response to contact with invading microorganisms.